1,4-di(propan-2-yl)pyrazole;methane;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;2-propan-2-yl-1,3,4-oxadiazole;2-propan-2-yl-1,3-oxazole;4-propan-2-yl-1H-pyrazole
C50H93N13O3 — CID 158811694
Data last refreshed: (MolForge compound catalog, from PubChem)
About 1,4-di(propan-2-yl)pyrazole;methane;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;2-propan-2-yl-1,3,4-oxadiazole;2-propan-2-yl-1,3-oxazole;4-propan-2-yl-1H-pyrazole
1,4-di(propan-2-yl)pyrazole;methane;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;2-propan-2-yl-1,3,4-oxadiazole;2-propan-2-yl-1,3-oxazole;4-propan-2-yl-1H-pyrazole (PubChem CID 158811694) has the molecular formula C50H93N13O3 and a molecular weight of 924.38 g/mol. Its IUPAC name is 1,4-di(propan-2-yl)pyrazole;methane;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;2-propan-2-yl-1,3,4-oxadiazole;2-propan-2-yl-1,3-oxazole;4-propan-2-yl-1H-pyrazole.
Molecular Properties
| Compound Name | 1,4-di(propan-2-yl)pyrazole;methane;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;2-propan-2-yl-1,3,4-oxadiazole;2-propan-2-yl-1,3-oxazole;4-propan-2-yl-1H-pyrazole |
|---|---|
| PubChem CID | 158811694 |
| Molecular Formula | C50H93N13O3 |
| Molecular Weight | 924.38 g/mol |
| Exact Mass | 923.75 |
| IUPAC Name | 1,4-di(propan-2-yl)pyrazole;methane;3-methyl-5-propan-2-yl-1,2,4-oxadiazole;1-methyl-4-propan-2-ylpyrazole;1-methyl-5-propan-2-ylpyrazole;2-propan-2-yl-1,3,4-oxadiazole;2-propan-2-yl-1,3-oxazole;4-propan-2-yl-1H-pyrazole |
| SMILES | C.C.C.C.CC(C)c1ccnn1C.CC(C)c1cn[nH]c1.CC(C)c1cnn(C(C)C)c1.CC(C)c1cnn(C)c1.CC(C)c1ncco1.CC(C)c1nnco1.Cc1noc(C(C)C)n1 |
| InChI | InChI=1S/C9H16N2.2C7H12N2.C6H10N2O.C6H10N2.C6H9NO.C5H8N2O.4CH4/c1-7(2)9-5-10-11(6-9)8(3)4;1-6(2)7-4-8-9(3)5-7;1-6(2)7-4-5-8-9(7)3;1-4(2)6-7-5(3)8-9-6;1-5(2)6-3-7-8-4-6;1-5(2)6-7-3-4-8-6;1-4(2)5-7-6-3-8-5;;;;/h5-8H,1-4H3;2*4-6H,1-3H3;4H,1-3H3;3-5H,1-2H3,(H,7,8);3-5H,1-2H3;3-4H,1-2H3;4*1H4 |
| InChIKey | IUTRYNXLLKNCIJ-UHFFFAOYSA-N |
| XLogP | 14.24 |
| TPSA | 186.01 Ų |
| H-Bond Donors | 1 |
| H-Bond Acceptors | 15 |
| Rotatable Bonds | 8 |
| Heavy Atoms | 66 |
| Complexity | — |
Lipinski Rule of Five
3 violations
| Rule | Value |
|---|---|
| MW ≤ 500 | 924.38 |
| LogP ≤ 5 | 14.24 |
| H-Bond Donors ≤ 5 | 1 |
| H-Bond Acceptors ≤ 10 | 15 |
Frequently Asked Questions
Browse: Molecules A–Z · all molecules A–Z · drugs A–Z · protein targets A–Z.
Sources
- PubChem CID 158811694 — identifiers, structure, computed properties (public domain)
How this page is built: methodology · editorial policy & corrections.
For research and educational use only — not medical advice. This page is compiled automatically from public databases. It is not written or reviewed by a clinician. Do not start, stop or change any treatment based on it; consult a qualified healthcare professional. Spotted an error? See our corrections policy or email hello@molforge.ai.